Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I can't believe the market has rewarded such fuckery (not that I mind).
As you know, HTFS (amongst the other learned here), there is no such evidence. Only...
Proof by assertion
Because CW has never had a deadline that he couldn't miss.
Agreed.
that speaks to the company's credibility. as does the reverse split. as does the recent cash raise. as do the clinical holds. as does the ema rejection.
new guy's plate is full.
How is ADXS a "late-stage" biotechnology company?
people are irrational. even rsu holders.
cherry picking.
smart robots just don't understand.
Share price is down, month over month. Are there really less sellers?
didn't some folks have cdxs a year or two ago?
too early, i guess.
Why do you think there is a payment associated with this milestone?
Did he say anything about raising capital or funding the remaining programs?
Is this right? Yahoo charts indicates TPIV has reverse split four times - for a net 30,000 to 1.
Wow.
I wonder what the OS for pembro alone would be. Has this been studied?
Please, tell us about this milestone. If it's not a pretend thing, please share a link.
uh, no.
already tested in samples from HUMAN PATIENTS!!
Good luck. There's some pretty strong downside resistance in the $12 area.
The net present value of ADXS warrants is less than zero due to transaction costs.
Avoid.
urban myth.
It's not in this company's nor this CEO's DNA not to dilute.
what do you mean by "new"?
why does it matter?
Amusing that you compare a nearly broke (again) company that has already reversed split it shares (once, so far) to AMZN, MSFT, etc.
I'm surprised you didn't include a Warrren Buffet lecture in your post.
Who's we? Employees? The executive suite?
Current common shareholders will be diluted into oblivion. Warrant holders just give up now.
Or they're milking it for as much cash as possible before the bankruptcy auction.
You're fooling yourself. The downside isn't limited, it's 100%.
it is not reasonable to expect that AMGN would abandon their fiduciary duties and pay that kind of crazy multiple for any company.
Especially for a company that can't accomplish anything.
It's not going to happen. Peanuts or not.
Thanks, jbog. I appreciate your posts. You're certainly right more than you're wrong.
ADXS clearly and demonstably has bad management.
It's not even arguable.
The market is saying the expected value of risk-adjusted, discounted cash flow is $1.72 per existing share.
Maybe ADXS is worth several billion dollars down the road but that matters little if the expected severe dilution happens during the intervening time.
$10, $20, $60? You're dreaming.
thanks for the link. it's not always easy to be a skeptic...
The stock price indicates that your conclusion is completely off base.
yawn.
as you know, patents are only valuable if they protect IP that generates cash.
everything except volume, share price, clinical hold, major dilution...
YOU ARE HEREBY NOTIFIED pursuant to Federal Rule of Civil
Procedure 23.1 and an Order of the U.S. District Court, District of New Jersey (the
"Court"), that the above-captioned stockholder derivative action (the "Action"), is
being settled (the "Settlement") on the terms set forth in the Stipulation of
Settlement dated as of October 2, 2017 (the "Stipulation").
they are crooks.
Or they go bust and shareholders get zero.
All publicly available information (for a company that supposedly cures cancer) reconciles to $1.80/share. Think about it...
800K covered and the price went down. What does that tell you?